We are live on ! Find out more
DRIO icon

DarioHealth
DRIO

14 hedge funds and large institutions have $408K invested in DarioHealth in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more capital inflows, than outflows

Capital inflows: $230K | Capital outflows: $28.7K

17% more funds holding

Funds holding: 12 → 14 (+2)

0.72% more ownership

Funds ownership: 1.18% → 1.9% (+0.72%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$155K
2
BlackRock
BlackRock
New York
+$34K
3
Citadel Advisors
Citadel Advisors
Florida
+$30.7K
4
Virtu Financial
Virtu Financial
New York
+$10.5K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$11.8K
2
Psagot Value Holdings
Psagot Value Holdings
Israel
-$10.5K
3
Bard Associates
Bard Associates
Illinois
-$6.53K

DRIO Hedge Fund Activity: Q2 2018 in Review

14 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2018, worth a combined $408K — up 36% from $300K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new DRIO positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $155K. The largest seller was Susquehanna International Group, cutting an estimated $11.8K.

  • 14 institutional investors held DarioHealth (DRIO) as of Q2 2018, up from 12 in Q1 2018.
  • Funds reported $408K of DarioHealth stock for Q2 2018, up 36% quarter-over-quarter.
  • 2 funds opened new DarioHealth positions in Q2 2018 and 0 closed out, a net change of +2 holders.
  • The largest DarioHealth buyer in Q2 2018 was Vanguard Group, an estimated $155K added.
  • The largest DarioHealth seller in Q2 2018 was Susquehanna International Group, an estimated $11.8K sold.

Based on aggregated 13F filings for Q2 2018.